Since 11 May and as of 8 September 2018, 131 Ebola cases were reported in the Democratic Republic of Congo (DRC), of which 100 are confirmed and 31 probable. Among the 131 cases, 90 had a fatal outcome. Eight health zones in two provinces have reported confirmed and probable EVD cases, including Mabalako, Beni, Butembo, Oicha, Masereka, Kalungata and Musienene health zones in North Kivu Province and Mandima Health Zone in Ituri Province.

Since May 2018 and as of 24 October 2018, there have been 251 Ebola virus disease cases (216 confirmed, 35 probable), including 162 deaths (127 of which were confirmed cases).

Since May 2018 and as of 10 November 2018, there have been 329 Ebola virus disease cases (294 confirmed, 35 probable), including 205 deaths (170 of which were confirmed cases).

Since the beginning of the outbreak and as of 23 January 2019, according to the Ministry of Health of the Democratic Republic of the Congo, there have been 715 Ebola virus disease cases (666 confirmed, 49 probable), including 443 deaths (394 in confirmed and 49 in probable cases).

After the Ebola virus disease outbreak was declared a Public Health Emergency of International Concern on 17 July 2019, ECDC updated its risk assessment for the EU/EEA on the on-going outbreak: the overall risk of introduction and further spread of the Ebola virus within the EU/EEA remains very low.

Two out of the four drugs tested in a multi-drug randomised control trial have been found more effective in treating Ebola, the World Health Organization announced on Monday. The Data and Safety Monitoring Board, an independent body that has been reviewing interim safety and efficacy data, has therefore recommended that the study be stopped and that all future patients be randomized to receive either REGN-EB3 or mAb114, in what is being considered an extension phase of the study.